These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 21307794)
1. Treatment of severe trigeminal headache in patients with pituitary adenomas. Freitas Tda S; Ferreira IC; Pereira Neto A; Neto OR; Gomes Gdo V; da Mota LA; Naves LA; Azevedo MF Neurosurgery; 2011 May; 68(5):1300-8; discussion 1308. PubMed ID: 21307794 [TBL] [Abstract][Full Text] [Related]
2. Cranial autonomic symptoms in patients with pituitary adenoma presenting with headaches. Wang SJ; Hung CW; Fuh JL; Lirng JF; Hwu CM Acta Neurol Taiwan; 2009 Jun; 18(2):104-12. PubMed ID: 19673362 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of headache severity before and after endoscopic transsphenoidal surgery for pituitary adenoma. Wolf A; Goncalves S; Salehi F; Bird J; Cooper P; Van Uum S; Lee DH; Rotenberg BW; Duggal N J Neurosurg; 2016 Jun; 124(6):1627-33. PubMed ID: 26495954 [TBL] [Abstract][Full Text] [Related]
6. Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions. Fleseriu M; Yedinak C; Campbell C; Delashaw JB J Neurosurg; 2009 Feb; 110(2):354-8. PubMed ID: 19012490 [TBL] [Abstract][Full Text] [Related]
7. [Microsurgical treatment of nonmeningeal tumors of the cavernous sinus]. Zhang R; Zhou LF; Mao Y Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1373-8. PubMed ID: 16029646 [TBL] [Abstract][Full Text] [Related]
8. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy. Zhang F; Chen J; Lu Y; Ding X J Clin Neurosci; 2009 Oct; 16(10):1273-5. PubMed ID: 19577475 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
12. Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center study. Siegel S; Weber Carneiro R; Buchfelder M; Kleist B; Grzywotz A; Buslei R; Bingel U; Brabant G; Schenk T; Kreitschmann-Andermahr I Endocrine; 2017 May; 56(2):325-335. PubMed ID: 28243973 [TBL] [Abstract][Full Text] [Related]
13. Pituitary incidentalomas: a single-centre experience. Anagnostis P; Adamidou F; Polyzos SA; Efstathiadou Z; Panagiotou A; Kita M Int J Clin Pract; 2011 Feb; 65(2):172-7. PubMed ID: 21235697 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and Impact of Postoperative Headaches in Nonfunctioning Pituitary Macroadenoma Patients: A Longitudinal Cohort Study. Jang MK; Park CG; Jang S; Kim EH World Neurosurg; 2020 Jan; 133():e633-e639. PubMed ID: 31604133 [TBL] [Abstract][Full Text] [Related]
15. Outcomes and quality of life assessment in patients undergoing endoscopic surgery for pituitary adenomas. Karabatsou K; O'Kelly C; Ganna A; Dehdashti AR; Gentili F Br J Neurosurg; 2008 Oct; 22(5):630-5. PubMed ID: 18686060 [TBL] [Abstract][Full Text] [Related]
16. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Wichers-Rother M; Hoven S; Kristof RA; Bliesener N; Stoffel-Wagner B Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):323-7. PubMed ID: 15216450 [TBL] [Abstract][Full Text] [Related]
17. Pituitary Adenoma and Non-acute Headache: Is There an Association, and Does Treatment Help? Gravdahl GB; Tronvik EA; Fougner SL; Solheim O World Neurosurg; 2016 Aug; 92():284-291. PubMed ID: 27132176 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience. Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875 [TBL] [Abstract][Full Text] [Related]
19. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
20. Giant pituitary adenomas--an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Sinha S; Sharma BS Br J Neurosurg; 2010 Feb; 24(1):31-9. PubMed ID: 20158350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]